NCT07146529Not yet recruiting
Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis
Source: ClinicalTrials.gov · Last updated 28 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The primary objective of the study is to determine the frequency of transmission of viruses carrying at least one antiretroviral resistance mutation in all participants newly diagnosed with HIV-1
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 30060 (estimated)
- First submitted
- 21 Aug 2025
- Start date
- Sept 2025
- Primary completion date
- Sept 2036
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Diseases
- HIV
- NCT number
- NCT07146529
What you commit to
- Study type: Observational
- Planned participants: 30060
- From Sept 2025 to the primary completion date, Sept 2036
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participant currently on antiretroviral treatment ;
Other
- Participant who objects to the use of their data ;
- Participant subject to legal protection measures (safeguard of justice).
Who the study is looking for
- Participant (male or female) aged 18 years or older ;
- Participant newly diagnosed in the laboratory, for whom mandatory HIV seropositivity reporting to Santé Publique France (SPF) is required ;
- Participant naïve to all antiretroviral treatments (except PrEP and/or post-exposure prophylaxis \[PEP\]) ;
- Participant with an available HIV resistance genotype, including amplification of at least reverse transcriptase and protease ;
- Participant who has not objected to participating in the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.